"Can Deliver Approximately 2 Billion Doses In 2021": German Firm BioNTech

German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses.

"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," said the company, referring to the additional dose that could be extracted from each vial of the vaccine.

A new factory in Marburg, Germany, is also expected to open in February, and would help to ramp up its production capacity.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)